Search This Blog

Monday, November 2, 2026

uniQure's Huntington's gene therapy receives FDA Priority Review

 with BLA accepted and PDUFA target action date of May 1, 2027

https://finviz.com/stock?t=QURE&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)